Document is current
Any future updates will be listed below
-
Authors
Nelson-Piercy, Cathy
Srisawat, Nattachai
Kashani, Kianoush https://orcid.org/0000-0003-2184-3683
Lumlertgul, Nuttha https://orcid.org/0000-0003-1506-4253
Murugan, Raghavan
Rhee, Harin
Chakravarthi, Raj
Surapaneni, Tarakeswari
Acharya, Anjali
Ankawi, Ghada
Bramham, Kate https://orcid.org/0000-0002-6272-7921
Cerda, Jorge https://orcid.org/0000-0001-7058-1697
Clark, Katherine https://orcid.org/0000-0001-7149-2899
Claure-Del Granado, Rolando https://orcid.org/0000-0002-8163-3779
Gowrishankar, Swarnalata
Luyckx, Valerie https://orcid.org/0000-0001-7066-8135
Menon, Shina
Poli-de-Figueiredo, Carlos E. https://orcid.org/0000-0002-7333-8884
Ramachandran, Raja
Sahay, Manisha https://orcid.org/0000-0001-5534-2516
Samavedam, Srinivas https://orcid.org/0000-0001-6737-8663
Shemies, Rasha https://orcid.org/0000-0002-0770-8023
Shetty, Manjunath S.
Wiles, Kate
Wium, Lizemarie
Wu, Vin-Cent https://orcid.org/0000-0001-7935-0991
Yadla, Manjusha
Ronco, Claudio https://orcid.org/0000-0002-6697-4065
Mehta, Ravindra L.
Ostermann, Marlies https://orcid.org/0000-0001-9500-9080
- License Information
-
More Information
Article History
Accepted: 16 June 2025
First Online: 18 July 2025
Competing interests
: C.N.-P. has received speakers fees from UCB and Sanofi unrelated to this manuscript. R.M. is a consultant for Baxter, Vantive and Fresenius, and has received grants from the US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and Vantive, unrelated to this study. M.O. has received research funding from Baxter and BioMérieux. K.K. declares patents for direct GFR measurement and net ultrafiltration calculator; consulting fees and travel support from Baxter Healthcare; research grants from Google; speaker honorarium from Nikkiso Critical Care Medical Supplies (Shanghai); funding from NIDDK grant; and research grants to his institution from the following companies: Fresenius, Spectral, ExThera, Renibus, Novartis and Astute Medical. K.B. has received consulting fees from GSK, Vertex, Maze, AstraZeneca and Bayer; honoraria from AstraZeneca, Boehringer Ingelheim and Vertex; and industry grants from AstraZeneca and Roche. R.C.-D.G. has received speaker honoraria from Nova Biomedical and Baxter Healthcare. R.L.M. has received consulting fees from Am Pharma, Baxter, Fresenius, Guard Therapeutics, Abbott, Sphingotec, Mallinckrodt, Novartis, Idorsia, Renasym, Abiomed and Alexion. S.M. has received research funding from the Gerber Foundation. The other authors declare no competing interests.
Free to read: This content has been made available to all.
